Advertisement
For elderly adults

Reduction of Chemical Exposure Cuts Diabetes in Elderly

0
Twenty-five percent reduction in chemical exposure could prevent 152,481 cases of diabetes in Europe
In an non-integrated dermatopathology practice

Use of Term ‘Rule Out’ May Delay Dermatopathology Diagnosis

0
Use on requisition form linked to longer time to diagnosis, increased use of pathology stains, sections
Genetic testing could help identify breast cancer patients at high risk for venous thromboembolism

Genetic Testing May Help ID VTE Risk in Breast Cancer Patients

0
Older breast cancer patients with increased genetic susceptibility receiving chemo have highest risk
Gene therapy shows promise in treating recessive dystrophic epidermolysis bullosa

Gene Tx Promising in Recessive Dystrophic Epidermolysis Bullosa

0
Grafts of patients' genetically modified skin improved healing of wounds in early study
Private sector employer-sponsored health insurance offerings were similar in 2013 and 2014

Few Changes in Employer-Sponsored Insurance 2013-2014

0
Only 3.5 percent of employers dropped coverage and 1.1 percent added coverage from 2013 to 2014
In research published online Oct. 28 in Science Immunology

New Way Bacteria Can Trigger Inflammation in Acne Identified

0
Findings may lead to new avenues for treatment
Low and high levels of high-density lipoprotein cholesterol are linked to increased mortality risk

Low and High HDL Tied to Increased Risk of Mortality

0
Study casts doubt on HDL as an independent cardiovascular disease risk factor
For patients with cutaneous melanoma

Whites Have Longest Survival in Cutaneous Melanoma

0
For stages I and III, black patients have significantly lower survival, increased hazard ratios
Epithelial thickness seems to be a marker for gastroesophageal reflux disease

Epithelial Thickness Is Marker for Gastroesophageal Reflux

0
Epithelial thickness is best performing criterion for GERD diagnosis in patients with upper GI symptoms
The estimated prevalence of current immunosuppression is 2.7 percent among the U.S. population

ISDA: U.S. Prevalence of Immunosuppression 2.7 Percent

0
Prevalence ranged from 1.8 to 3.1 percent; highest among women, whites, those aged 50 to 59 years